Combined continuous glucose monitoring and subcutaneous insulin infusion versus self-monitoring of blood glucose with optimized multiple injections in people with type 1 diabetes: A randomized crossover trial.
Ilaria DicembriniLaura PalaMariasmeralda CaliriSilvia MinardiClaudia CosentinoMatteo MonamiEdoardo MannucciPublished in: Diabetes, obesity & metabolism (2020)
This study suggests that CSII + CGM improves glycaemic control without relevant safety issues in type 1 diabetes, in comparison with MDI + SMBG.